Serum complement C2 levels in patients suffering from cystic fibrosis (CF).

A. László, G. Füst, A. Pánya, K. Gyurkovits

Research output: Contribution to journalArticle

Abstract

Serum C2 complement levels were measured in 17 children suffering from CF, 17 with obstructive bronchitis, and 7 control children. No correlation was found between the C2 level and the clinical stage in Shwachman score, the HLA B7 or B18 antigens and the ventilation functional parameters. The mean serum C2 complement level did not differ in the three investigated groups, but in 5 of the 17 CF patients the serum C2 was diminished according to the possibility of C2 complement heterozygosity. The CF patients with diminished C2 complement levels exhibited HLA B7, B12 or B35 antigens. The serum C2 complement levels were significantly higher in the HLA B18 antigen-carrier CF homozygotes.

Original languageEnglish
Pages (from-to)289-292
Number of pages4
JournalActa Paediatrica Hungarica
Volume29
Issue number3-4
Publication statusPublished - 1988

Fingerprint

Complement C2
Cystic Fibrosis
HLA-B18 Antigen
HLA-B7 Antigen
Serum
HLA-B35 Antigen
Bronchitis
Homozygote
Ventilation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Serum complement C2 levels in patients suffering from cystic fibrosis (CF). / László, A.; Füst, G.; Pánya, A.; Gyurkovits, K.

In: Acta Paediatrica Hungarica, Vol. 29, No. 3-4, 1988, p. 289-292.

Research output: Contribution to journalArticle

@article{01f09606863a4455b9ace68e1ccac438,
title = "Serum complement C2 levels in patients suffering from cystic fibrosis (CF).",
abstract = "Serum C2 complement levels were measured in 17 children suffering from CF, 17 with obstructive bronchitis, and 7 control children. No correlation was found between the C2 level and the clinical stage in Shwachman score, the HLA B7 or B18 antigens and the ventilation functional parameters. The mean serum C2 complement level did not differ in the three investigated groups, but in 5 of the 17 CF patients the serum C2 was diminished according to the possibility of C2 complement heterozygosity. The CF patients with diminished C2 complement levels exhibited HLA B7, B12 or B35 antigens. The serum C2 complement levels were significantly higher in the HLA B18 antigen-carrier CF homozygotes.",
author = "A. L{\'a}szl{\'o} and G. F{\"u}st and A. P{\'a}nya and K. Gyurkovits",
year = "1988",
language = "English",
volume = "29",
pages = "289--292",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "3-4",

}

TY - JOUR

T1 - Serum complement C2 levels in patients suffering from cystic fibrosis (CF).

AU - László, A.

AU - Füst, G.

AU - Pánya, A.

AU - Gyurkovits, K.

PY - 1988

Y1 - 1988

N2 - Serum C2 complement levels were measured in 17 children suffering from CF, 17 with obstructive bronchitis, and 7 control children. No correlation was found between the C2 level and the clinical stage in Shwachman score, the HLA B7 or B18 antigens and the ventilation functional parameters. The mean serum C2 complement level did not differ in the three investigated groups, but in 5 of the 17 CF patients the serum C2 was diminished according to the possibility of C2 complement heterozygosity. The CF patients with diminished C2 complement levels exhibited HLA B7, B12 or B35 antigens. The serum C2 complement levels were significantly higher in the HLA B18 antigen-carrier CF homozygotes.

AB - Serum C2 complement levels were measured in 17 children suffering from CF, 17 with obstructive bronchitis, and 7 control children. No correlation was found between the C2 level and the clinical stage in Shwachman score, the HLA B7 or B18 antigens and the ventilation functional parameters. The mean serum C2 complement level did not differ in the three investigated groups, but in 5 of the 17 CF patients the serum C2 was diminished according to the possibility of C2 complement heterozygosity. The CF patients with diminished C2 complement levels exhibited HLA B7, B12 or B35 antigens. The serum C2 complement levels were significantly higher in the HLA B18 antigen-carrier CF homozygotes.

UR - http://www.scopus.com/inward/record.url?scp=0024154451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024154451&partnerID=8YFLogxK

M3 - Article

C2 - 3269267

AN - SCOPUS:0024154451

VL - 29

SP - 289

EP - 292

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 3-4

ER -